Innovus Pharmaceuticals, Inc. (INNV) Analysts See $-0.01 EPS; EP Energy Class A (EPE) Shorts Down By 1.1%

Analysts expect Innovus Pharmaceuticals, Inc. (OTCMKTS:INNV) to report $-0.01 EPS on April, 1.They anticipate $0.00 EPS change or 0.00% from last quarter’s $-0.01 EPS. After having $-0.01 EPS previously, Innovus Pharmaceuticals, Inc.’s analysts see 0.00% EPS growth. It closed at $0.046 lastly. It is down 0.00% since March 15, 2018 and is . It has underperformed by 4.37% the S&P500.

EP Energy Corporation Class A (NYSE:EPE) had a decrease of 1.1% in short interest. EPE’s SI was 8.61 million shares in March as released by FINRA. Its down 1.1% from 8.70 million shares previously. With 499,800 avg volume, 17 days are for EP Energy Corporation Class A (NYSE:EPE)’s short sellers to cover EPE’s short positions. The SI to EP Energy Corporation Class A’s float is 15.95%. The stock decreased 11.95% or $0.0741 during the last trading session, reaching $0.5459. About 1.75M shares traded or 125.97% up from the average. EP Energy Corporation (NYSE:EPE) has declined 63.43% since March 15, 2018 and is downtrending. It has underperformed by 67.80% the S&P500. Some Historical EPE News: 15/03/2018 – ENTERPRISE GROUP INC E.TO – QTRLY EPS $0.01; 15/03/2018 – HK Bourse: Announcement From China Fire Safety Enterprise Group Ltd; 06/03/2018 – ENTERPRISE GROUP INC – PROCEEDS FROM TRANSACTION WOULD BE USED TO REDUCE ENTERPRISE’S DEBT; 10/04/2018 – Enterprise Group Deploys Proprietary Asset Tracking & Dispatch Software “Star” to Lower Costs and Increase Margins; 17/05/2018 – S&PGR Rates EP Energy’s New 1.125-Lien Nts ‘B’; Recov Rtg: ‘1’; 06/03/2018 – Enterprise Group Announces Letter of Intent to Divest the Business of Calgary Tunnelling & Horizontal Augering; 10/04/2018 – Enterprise Group Deploys Proprietary Asset Tracking & Dispatch Software “Star” to Lower Costs and Increase Margins; 27/03/2018 – SHANGHAI SANMAO ENTERPRISE GROUP 600689.SS SAYS SHARE TRADE TO HALT FROM MARCH 28 AMID UNUSUAL SHARE PRICE MOVEMENTS; 28/03/2018 – CHINA HEALTHCARE ENTERPRISE GROUP LTD – FY LOSS ATTRIBUTABLE HK$128.4 MLN VS LOSS OF HK$82.6 MLN; 10/05/2018 – Enterprise Group 1Q EPS 6c

Investors sentiment increased to 1.07 in Q4 2018. Its up 0.07, from 1 in 2018Q3. It increased, as 11 investors sold EP Energy Corporation shares while 19 reduced holdings. 11 funds opened positions while 21 raised stakes. 160.72 million shares or 1.13% less from 162.56 million shares in 2018Q3 were reported. State Bank Of America Corporation De has 24,099 shares for 0% of their portfolio. Invesco Ltd holds 0% in EP Energy Corporation (NYSE:EPE) or 438,834 shares. Dimensional Fund Lp accumulated 515,617 shares. Bnp Paribas Arbitrage owns 62,909 shares for 0% of their portfolio. Voya Invest Management Ltd Liability Company invested in 12,968 shares. Tiaa Cref Mngmt Limited Liability Company stated it has 0% in EP Energy Corporation (NYSE:EPE). Moreover, Apollo Management Ltd Partnership has 0.8% invested in EP Energy Corporation (NYSE:EPE). New York-based Goldman Sachs Group has invested 0% in EP Energy Corporation (NYSE:EPE). The New York-based Clearbridge Llc has invested 0% in EP Energy Corporation (NYSE:EPE). Hrt Financial Ltd Company reported 11,676 shares or 0% of all its holdings. Tudor Investment Et Al holds 0% or 79,862 shares in its portfolio. Riverstone Hldg Ltd Liability Company accumulated 1.04% or 31.28M shares. Vanguard Group owns 3.66 million shares or 0% of their US portfolio. Wolverine Asset Mngmt Limited Liability stated it has 203,073 shares or 0% of all its holdings. Royal Bank Of Canada, a Ontario – Canada-based fund reported 199,586 shares.

EP Energy Corporation, an independent exploration and production company, engages in the exploration for and the acquisition, development, and production of oil, natural gas, and natural gas liquids in the United States. The company has market cap of $140.25 million. The firm has interests in three primary areas, such as the Eagle Ford Shale located in South Texas; the Wolfcamp Shale located in Permian Basin in West Texas; and the Altamont Field located in the Uinta Basin in Northeastern Utah. It currently has negative earnings. As of December 31, 2016, it had proved reserves of 432.4 million barrels of oil equivalent and had average net daily production of 87,641 barrel of oil equivalent/per day.

More recent EP Energy Corporation (NYSE:EPE) news were published by: Prnewswire.com which released: “EP Energy Announces Fourth Quarter And Full Year 2018 Results – PRNewswire” on March 14, 2019. Also Benzinga.com published the news titled: “Earnings Scheduled For March 14, 2019 – Benzinga” on March 14, 2019. Bizjournals.com‘s news article titled: “Another Houston energy co. gets delisting warning over low stock price – Houston Business Journal” with publication date: January 10, 2019 was also an interesting one.

Innovus Pharmaceuticals, Inc., a pharmaceutical company, engages in the commercialization, licensing, and development of non-prescription medicine and consumer care products in the United States. The company has market cap of $11.26 million. The Company’s products include Zestra, a proprietary blend of essential oils to enhance desire, arousal, and satisfaction in women; EjectDelay, an over-the-counter monograph-compliant benzocaine gel for premature ejaculation; Sensum+, a non-medicated cream that enhances penile sensitivity; Zestra Glide, a water longer lasting lubricant; Vesele, a proprietary oral supplement of Arginine sexual and cognitive functions; and Androferti, a natural supplement to support overall male reproductive health and sperm quality. It currently has negative earnings. The firm also offers Beyond Human testosterone booster, Ketones, krill oil, Omega 3 fish oil, Vision Formula, blood sugar, colon cleanse, green coffee extract, and growth agent; RecalMax for brain health; and UriVarx, a proprietary supplement for overactive bladder and urinary incontinence.

EP Energy Corporation (NYSE:EPE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.